Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 5, 2010, Pages 1333-1338

  Eisbruch, Avraham ^a   Harris, Jonathan ^b   Garden, Adam S ^c   Chao, Clifford K S ^c   Straube, William ^d   Harari, Paul M ^e   Sanguineti, Giuseppe ^f   Jones, Christopher U ^g   Bosch, Walter R ^d   Ang, K Kian ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b American College of Radiology   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^g Radiation Oncology Center   (United States)

Author keywords

Head and neck cancer; Intensity modulated radiation therapy; Oropharynx cancer

Indexed keywords

HEAD-AND-NECK CANCER; IMAGE GUIDED THERAPY; INTENSITY MODULATED RADIATION THERAPY; OROPHARYNGEAL; OROPHARYNGEAL CANCER; OROPHARYNX CANCER; OSTEORADIONECROSIS; PLANNING TARGET VOLUMES; RADIATION THERAPY ONCOLOGY GROUPS; REGIONAL FAILURES; SECOND PRIMARY CANCER; TUMOR CONTROL; XEROSTOMIA;

CHEMOTHERAPY; PHYSICAL THERAPY; QUALITY ASSURANCE; SOCIETIES AND INSTITUTIONS; TOTAL QUALITY MANAGEMENT; TOXICITY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OROPHARYNX CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; SKIN TOXICITY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS; QUALITY CONTROL; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; TUMOR BURDEN;

EID: 77949564251     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.011     Document Type: Article

References (23)

1. Chao K.S., Ozyigit G., Blanco A.I., et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume. Int J Radiat Oncol Biol Phys 59 (2004) 43-50
2. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: The MSKCC experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
3. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
4. Garden A.S., Morrison W.H., Wong P.F., et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67 (2007) 438-444
5. Yao, Nguyen T., Buatti J.M., et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with IMRT. Am J Clin Oncol 29 (2006) 606-612
6. Sanguineti G., Gunn G.B., Endres E.J., et al. Pattern of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 72 (2008) 737-746
7. Molineu A., Followil D.S., Balter P.A., et al. Design and implementation of an anthropomorphic quality assurance phantom for IMRT. Int J Radiat Oncol Biol Phys 63 (2005) 577-588
8. Fleming T. One-Sample multiple testing procedure for Phase II clinical trials. Biometrics 38 (1982) 143-151
9. Brizel D.M., Wasserman T.H., Hence M., et al. Phase III randomized trial of amifostine in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
10. Kalbfleisch J.D., and Prentice R.L. The statistical analysis of failure time data (1980), John Wiley and Sons, New York
11. Palta J.R., Deye J.A., Ibbott G.S., et al. Credentialing of institutions for IMRT. Int J Radiat Oncol Biol Phys 59 (2004) 1257-1262 [letter]
12. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. Report 62 (1999), ICRU, Bethesda, MD
13. IMRT Collaborative Working Group. Intensity modulated radiation therapy: Current status. Int J Radiat Oncol Biol Phys 51 (2001) 880-914
14. Ezzell G.A., Galvin J.M., Low D., et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT. Med Phys 30 (2003) 2089-2115
15. Rischin D., Peters L., O'Sullivan B., et al. Phase III study of tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced head and neck cancer. J Clin Oncol 26 (2008) 18S-1010s [abstract #LBA6008]
16. Seung S., Bae J., Solhjem M., et al. IMRT for head-and-neck cancer in the community. Int J Radiat Oncol Biol Phys 72 (2008) 1075-1081
17. Kumar B., Cordell K.G., Lee J.S., et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy in oropharyngeal cancer. J Clin Oncol 26 (2008) 3128-3137
18. Lauve A., Morris M., Schmidt-Ullrich R., et al. Simultaneous integrated boost IMRT for head-and-neck carcinomas: II-clinical results. Int J Radiat Oncol Biol Phys 60 (2004) 374-387
19. Eisbruch A., and Gregoire V. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol 19 (2009) 43-52
20. Amosson C.M., The B.S., Garg A.K., et al. Accelerated fractionation for head and neck cancer using SMART boost. Int J Radiat Oncol Biol Phys 57 (2003) S306 [abstract 1076]
21. Ben David M.A., Diamante M., Radawski J.D., et al. Lack of osteoradionecrosis of the mandible after IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 396-402
22. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
23. Kam M.M.K., Leung S.F., Zee B., et al. Impact of IMRT on salivary function in nasopharyngeal carcinoma. J Clin Oncol 25 (2007) 4873-4879